mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.7 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.7 |